Neurotoxin-mediated potent activation of the axon degeneration regulator SARM1

Author:

Loreto Andrea1ORCID,Angeletti Carlo2,Gu Weixi3ORCID,Osborne Andrew1,Nieuwenhuis Bart1ORCID,Gilley Jonathan1ORCID,Merlini Elisa1,Arthur-Farraj Peter1ORCID,Amici Adolfo2ORCID,Luo Zhenyao3,Hartley-Tassell Lauren4,Ve Thomas4,Desrochers Laura M5,Wang Qi5,Kobe Bostjan3ORCID,Orsomando Giuseppe2ORCID,Coleman Michael P1

Affiliation:

1. John van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge

2. Department of Clinical Sciences (DISCO), Section of Biochemistry, Polytechnic University of Marche

3. School of Chemistry and Molecular Biosciences, Institute for Molecular Bioscience and Australian Infectious Diseases Research Centre, University of Queensland

4. Institute for Glycomics, Griffith University

5. Neuroscience, BioPharmaceuticals R and D, AstraZeneca

Abstract

Axon loss underlies symptom onset and progression in many neurodegenerative disorders. Axon degeneration in injury and disease is promoted by activation of the NAD-consuming enzyme SARM1. Here, we report a novel activator of SARM1, a metabolite of the pesticide and neurotoxin vacor. Removal of SARM1 completely rescues mouse neurons from vacor-induced neuron and axon death in vitro and in vivo. We present the crystal structure of the Drosophila SARM1 regulatory domain complexed with this activator, the vacor metabolite VMN, which as the most potent activator yet known is likely to support drug development for human SARM1 and NMNAT2 disorders. This study indicates the mechanism of neurotoxicity and pesticide action by vacor, raises important questions about other pyridines in wider use today, provides important new tools for drug discovery, and demonstrates that removing SARM1 can robustly block programmed axon death induced by toxicity as well as genetic mutation.

Funder

Wellcome Trust

Biotechnology and Biological Sciences Research Council

Università Politecnica delle Marche

National Health and Medical Research Council

Sight Research UK

Australian Research Council

Publisher

eLife Sciences Publications, Ltd

Subject

General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3